Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2005-03-15
2005-03-15
Kunz, Gary (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C424S489000, C424S443000, C424S434000, C424S400000, C514S826000
Reexamination Certificate
active
06866839
ABSTRACT:
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
REFERENCES:
patent: 3994974 (1976-11-01), Murakami et al.
patent: 4380534 (1983-04-01), Fukui
patent: 4814161 (1989-03-01), Jinks
patent: 4917676 (1990-04-01), Heiber
patent: 4975466 (1990-12-01), Böttcher et al.
patent: 5795564 (1998-08-01), Aberg et al.
patent: 6068833 (2000-05-01), Aberg et al.
patent: 6589508 (2003-07-01), Aberg et al.
patent: 2255503 (1992-11-01), None
patent: WO9205147 (1992-04-01), None
Murase et al., “Absolute Configurations of four Isomers of 3-Formamido-4-hydroxy-β-[[N-(p-methoxy-α-methylphenethyl)amino]methyl]benyl Alcohol, a Potent β-Adrenoreceptor Stimulant,”Chem. Pharm. Bull, 26:1123-29 (1978).
Testa et al., “Racemates Versus Enatiomers in Drug Development: Dogmatism or Pragmatism?”Chirality, 2:129-133 (1990).
“Comparison of the Action of BD 40 A and some Other β-Adrenoceptor Stimulants of the Isolated Trachea and Atria of the Guinea Pig” H. IdaArzneim.-Forsch.26, 839-842 (1976).
“Cardiorespiratory Activities of 3-Formylamino-4-hydroxy α-(N-1-methyl-2-methoxyphenethylaminomethyl)-benzylalcohol-bemifumarate (BD 40A) and some other β-Adrenoceptor Stimulants in Conscious Guinea Pigs” H. IdaArzneim.-Forsch.26, 1337-1340 (1976).
“New β-Adrenoreceptor Stimulants. Studies on 3-Acylamino-4-hydroxy-α-(N-substituted aminomethyl)benzyl Alcohols” Murase et al.Chem. Pharm. Bull.25(6) 1368-1377 (1977).
“Steric Aspects of Agonism and Antagonism at β-Adrenoceptors: Synthesis of and Pharmacological Experiments With the Enantiomers of Formoterol and Their Diasteromers” Trofast et al.Chirality3 443-450 (1991).
“A Three-Month Comparison of Twice Daily Inhaled Formoterol Versus Four Times Daily Inhaled Albuterol in the Management of Stable Asthma1-3” Keston et al.Am. Rev. Respir. Dis.144 622-625 (1991).
“Absolute Configurations of Four Isomers of 3-Formamido-4-hydroxy-. . . ” Murase et al.Chem. Pharm. Bull.26, 1123-29 (1978).
“β-Adrenoceptor Ligands: Characterization and Quantification of Drug Effects” LemoineQuant. Struct.-Act. Relat.11, 211-218 (1992).
“Stereoselectivity in pharmacodynamics and pharmacokinetics” AriënsSchjweiz. med. Wochenschr.120, 131-134 (1990).
“Racemic therapeutics-ethical and regulatory aspects” AriënsEur. J. Clin. Pharmacol41, 89-93 (1991).
“Racemates Versus Enantiomers in Drug Development: Dogmatism . . . ” Testa et al.Chirality2, 129-133 (1990).
Aberg Gunnar
Morley John
Haghighatian Mina
Hansen Philip E.
Heslin Rothenberg Farley & & Mesiti P.C.
Kunz Gary
Sepracor Inc.
LandOfFree
Methods and compositions for treating pulmonary disorders... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating pulmonary disorders..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating pulmonary disorders... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3392457